[Federal Register Volume 65, Number 211 (Tuesday, October 31, 2000)]
[Notices]
[Pages 64965-64966]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-27835]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Advisory Committee; Renewals

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
renewals of certain FDA advisory committees by the Commissioner of Food 
and Drugs (the Commissioner). The Commissioner has determined that it 
is in the public interest to renew the charters of the committees 
listed below for an additional 2 years beyond charter expiration date. 
The new charters will be in effect until the dates of expiration listed 
below. This notice is issued under the Federal Advisory Committee Act 
of October 6, 1972 (Pubic Law 92-463 (5 U.S.C. app. 2)).

DATES: Authority for these committees will expire on the dates 
indicated below unless the Commissioner formally determines that 
renewal is in the public interest.

 
------------------------------------------------------------------------
         Name of committee                    Date of expiration
------------------------------------------------------------------------
Gastrointestinal Drugs Advisory      March 3, 2002
 Committee
Advisory Committee for Reproductive  March 23, 2002
 Health Drugs
Arthritis Advisory Committee         April 5, 2002
Veterinary Medicine Advisory         April 24, 2002
 Committee
Anesthetic and Life Support Drugs    May 1, 2002
 Advisory Committee
Blood Products Advisory Committee    May 13, 2002
Pulmonary-Allergy Drugs Advisory     May 30, 2002
 Committee
Drug Abuse Advisory Committee        May 31, 2002
Science Advisory Board to the        June 2, 2002
 National Center for Toxicological
 Research
Peripheral and Central Nervous       June 4, 2002
 System Drugs Advisory Committee
Psychopharmacologic Drugs Advisory   June 4, 2002
 Committee
Transmissible Spongiform             June 9, 2002
 Encephalopathies Advisory
 Committee
Science Board to the Food and Drug   June 26, 2002
 Administration
Allergenic Products Advisory         July 9, 2002
 Committee
Cardiovascular and Renal Drugs       August 27, 2002
 Advisory Committee
Endocrinologic and Metabolic Drugs   August 27, 2002
 Advisory Committee
Oncologic Drugs Advisory Committee   September 1, 2002
------------------------------------------------------------------------


[[Page 64966]]


FOR FURTHER INFORMATION CONTACT: Donna M. Combs, Committee Management 
Office (HFA-306), Food and Drug Administration, 5600 Fishers Lane, 
Rockville MD 20857, 301-827-5496.

    Dated: October 23, 2000.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 00-27835 Filed 10-30-00; 8:45 am]
BILLING CODE 4160-01-F